125511

: It is used to help control low blood calcium (hypocalcemia) in patients who do not respond well to standard calcium and vitamin D treatments alone.

BLA 125511 is the official FDA application number for , a bioengineered hormone approved as an adjunct therapy for patients with hypoparathyroidism . 125511

In the realm of environmental science, "125511" is the article identifier for a 2020 study titled . : It is used to help control low